Advances in molecular innate immune regulation in the development and therapeutic strategies of allergic rhinitis vaccines
-
By
-
Yiting Liu
-
Cuida Meng
-
Jichao Sha
-
Dongdong Zhu
-
Qingjia Sun
-
Nan Wu
-
June 5, 2026
-
Clinical Scorecard: Recent Progress in Molecular Regulation of Innate Immunity for Developing and Enhancing Allergic Rhinitis Vaccines
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Involvement of Toll-like receptors (TLRs) in modulating immune responses and enhancing allergen immunotherapy (AIT). |
| Target Population | |
| Care Setting | |
Key Highlights
Guideline-Based Recommendations
Diagnosis
- Diagnosis of allergic rhinitis is based on clinical history and symptom assessment.
Management
- Conventional treatments include antihistamines, corticosteroids, and leukotriene receptor antagonists.
Monitoring & Follow-up
- Monitor patient response to allergen immunotherapy and adjust treatment as necessary.
Risks
- Prolonged allergen immunotherapy may lead to suboptimal responses or poor adherence.
Patient & Prescribing Data
Patients with allergic rhinitis requiring immunotherapy.
Allergen immunotherapy induces immune tolerance but requires prolonged treatment.
Clinical Best Practices
Related Resources & Content
